(Q46307945)

21 December 2017

title

Bone remodeling in postmenopausal women who discontinued denosumab treatment: off-treatment biopsy study (English)

1 reference

21 December 2017

0 references

Jacques P Brown

1

1 reference

21 December 2017

David W Dempster

2

1 reference

21 December 2017

Beiying Ding

3

1 reference

21 December 2017

Ricardo Dent-Acosta

4

1 reference

21 December 2017

Javier San Martin

5

1 reference

21 December 2017

Andreas Grauer

6

1 reference

21 December 2017

Rachel B Wagman

7

1 reference

21 December 2017

Jose Zanchetta

8

1 reference

21 December 2017

publication date

1 November 2011

1 reference

21 December 2017

Journal of Bone and Mineral Research

published in

1 reference

21 December 2017

volume

26

1 reference

21 December 2017

issue

11

1 reference

21 December 2017

page(s)

2737-2744

1 reference

21 December 2017

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

cites work

1 reference

Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass.

21 January 2018

1 reference

Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial

21 January 2018

1 reference

Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studies.

21 January 2018

1 reference

Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate.

21 January 2018

1 reference

Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial

21 January 2018

1 reference

A concordance correlation coefficient to evaluate reproducibility

21 January 2018

1 reference

Alendronate prevents loss of bone density associated with discontinuation of hormone replacement therapy: a randomized controlled trial

21 January 2018

1 reference

The effect of postmenopausal estrogen therapy on bone density in elderly women

21 January 2018

1 reference

Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers

21 January 2018

1 reference

Bone mass response to discontinuation of long-term hormone replacement therapy: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Safety Follow-up Study

21 January 2018

1 reference

Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Effect of 1 year of discontinuation of raloxifene or estrogen therapy on bone mineral density after 5 years of treatment in healthy postmenopausal women

21 January 2018

1 reference

Effect of withdrawal of hormone replacement therapy on bone mass and bone turnover: the OFELY study.

21 January 2018

1 reference

Bone turnover in postmenopausal women after withdrawal of estrogen/gestagen replacement therapy.

21 January 2018

1 reference

Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women

21 January 2018

1 reference

Changes in bone density and turnover after alendronate or estrogen withdrawal.

21 January 2018

1 reference

Fracture risk remains reduced one year after discontinuation of risedronate

21 January 2018

1 reference

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

21 January 2018

1 reference

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JBMR.448

1 reference

21 December 2017

1 reference

21 December 2017